Researchers call on regulators to reduce risks of AI in medicine

Continuous monitoring is critical if regulatory agencies such as the Food and Drug Administration are to reduce the risk in artificial and machine learning-based medical technology.


More for you

Loading data for hdm_tax_topic #better-outcomes...